在神经疾病中微质极化过程中,糖溶性重编程
Xiaoting Li1,2, Congcong Fang3, Yina Li1,2
1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
Frontiers in immunology
|October 23, 2025
概括
中枢神经系统的免疫细胞微质细胞根据新陈代谢改变其功能. 针对他们的葡萄糖代谢提供了一种治疗神经系统疾病的新方法.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
背景情况:
- 微质细胞是中枢神经系统 (CNS) 中关键的免疫细胞,参与神经系统疾病.
- 微质可塑性允许由微环境线索驱动的多样化表型.
- 代谢重编程,特别是葡萄糖代谢,对微质的极化和功能进行了关键调节.
研究的目的:
- 在神经疾病中审查微质偏振和甘油性重编程.
- 探索代谢重编程在中枢神经系统病理中的作用.
- 要突出进一步研究微质代谢学和表观遗传学的需要.
主要方法:
- 关于微质偏振的文献综述.
- 分析中枢神经系统疾病中的代谢重编程.
- 探索微质功能中的糖解路径.
主要成果:
- 微质极化与葡萄糖代谢重编程密切相关.
- 亲炎性微质主要使用糖解;抗炎性微质使用氧化酸化.
- 向微质糖解是一种潜在的治疗策略,用于中枢神经系统疾病.
结论:
- 微质的代谢重编程是它们在神经系统疾病中的作用的核心.
- 调节微质代谢,特别是糖解,可能提供新的治疗策略.
- 需要进一步研究微质中的代谢学和表观遗传学的相互作用.
相关概念视频
Ligand-gated Ion Channels
11.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
11.4K
Drugs Affecting Neurotransmitter Synthesis
2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


